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SummAry – invasive lobular carcinoma is a distinct biological entity with several histologic 
variants the prognostic value of which is not fully elucidated. The aim of this study was to deter-
mine the immunohistochemical expression of estrogen receptors (er) and progedterone receptors 
(Pr) in subtypes of lobular breast carcinoma (classic and variant types) and to correlate them with 
clinical and tumor parameters. fifty lobular carcinomas, i.e. 33 classic and 17 variant, were analy-
zed. The classic type was more common (66%) and found in older women (61 years of age), smaller 
in size (1.5 cm), with n0 status and modestly positive er and Pr. The variant types were more 
frequent in younger women (55 years of age), larger in size (2.5 cm), with n1 status and maximal 
positive er and Pr. er was expressed in 82% and Pr in 78% of all tumors, mostly with maximal 
expression. Only one tumor of the classic type was Her/2neu 3+, er and Pr-. er expression 
was significantly associated with a decreased incidence of other proliferative lesions (p=0.043). The 
total sample and the classic type were characterized by a significant positive correlation between 
er and Pr (p=0.004) and between tumor size and n status (p=0.005), and by negative correlation 
between Her/2neu and n status (p=0.042). in variant types, larger tumors were related to higher 
n (p=0.021), while higher er expression was associated with smaller tumors (p=0.044). The study 
indicated distinct biological features of lobular carcinoma subtypes and the need for a more selective 
therapeutic approach. 
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Introduction
invasive lobular carcinoma (ilC), as reported by 
different authors, accounts for 0.6%-20% of all inva-
sive breast carcinomas1-3. in the last 20 years, the in-
cidence of ilC has increased in women over 50 years 
of age, which may be related to their postmenopausal 
status4,5. because of the lack of desmoplastic reac-
tion of the adjacent stroma, lobular tumors are often 
clinically nonpalpable3; it is one of the reasons for the 
high number of false-negative mammographic and 
diagnostic cytology reports, so it is important to find 
and determine new, more reproducible clinical and 
morphological parameters in the current diagnostic 
approach. it seems that ilC has a distinct biologi-
cal behavior compared with invasive ductal carcinoma 
(idC) and other special types of breast carcinoma. 
Some authors suggest that ilC is more dependent on 
hormones than idC6,7. despite its less aggressive bio-
logical phenotype, the average survival and recurrence 
rates are similar between women with ilC and those 
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with idC7. ilC shows both diversity in grade and 
morphology, with a number of distinct variants. The 
prognostic utility of grading ilC, however, has not 
yet been fully elucidated.
The main purpose of our study was to determine 
the expression of estrogen and progesterone hormone 
receptors (er and Pr) in different histologic subtypes 
of lobular carcinoma and to correlate er and Pr sta-
tus with epidemiological, clinical and morphological 
features of ilC.
Patients and Methods
The study was performed by examining 50 cases 
of ilC diagnosed from the surgically removed speci-
mens at ljudevit Jurak university department of Pa-
thology in the period from January 1, 2003 to decem-
ber 31, 2008. tumor tissue was fixed in 10% formalin, 
embedded in paraffin, cut in 5-µm sections, deparaf-
finized and stained with hematoxylin and eosin. ilC 
was subclassified as classic type and variant types (in-
cluding solid, pleomorphic, alveolar and mixed types). 
The classic pattern of ilC was characterized by pro-
liferation of small round or oval cells without cohesion 
between them, dispersed individually through the 
stroma, arranged in single file linear cords known as 
‘indian’s file’ or concentric ‘targetoid’ pattern around 
normal ducts3. The solid subtype was characterized by 
sheets of cells with lobular morphology but they were 
often more pleomorphic and had a higher frequency 
of mitoses than the classic type. Alveolar pattern was 
made of similar cells, which were arranged in globular 
aggregates of at least 20 cells. in pleomorphic variant, 
tumor cells showed a typical growth pattern of lobular 
carcinoma but with a greater degree of cellular atypia 
and pleomorphism than the classic or other types of 
ilC and often included signet ring cells or pleomor-
phic cells3. mixed group was made of an admixture of 
the classic type with one or more of other patterns. 
immunohistochemistry for er, Pr and the onco-
protein Her2/neu was performed with standardized 
kits (dAKO, glostrup, denmark). tissue sections 
were subjected to antigen retrieval in a microwave 
2x5 min in citrate buffer solution pH 6.0, Chem mate 
buffer for Antigen retrival diluted 1:10. upon ter-
mination of the antigen retrieval step, the slides were 
left in the buffer for at least 20 minutes at room tem-
perature. The slides were stained immunohistochemi-
cally by labeled streptavidin biotin method (lSAb) as 
visualization system on a dako tech mate automatic 
immunostainer using the microwave streptavidin im-
munoperoxidase (mSiP) protocol. Scoring for estro-
gen and progesterone receptors was done by counting 
positive tumor cells in ‘hot spot’ and grading as nega-
tive (<5% positive tumor cells), 1+ (5%-10% positive 
tumor cells), 2+ (10%-50% positive tumor cells) and 
3+ (>50% positive tumor cells). Scoring for Her2/neu 
was done using the guidelines for scoring Herceptest, 
dako. 
data were analyzed by descriptive statistics and 
checked for normal distribution by the Kolmogorov-
Smirnov test. differences in qualitative data were ana-
lyzed by χ2-test, whereas quantitative differences were 
determined by mann-whitney u test. furthermore, 
Spearman’s correlation coefficient was calculated on 
comparing ordinal variables, whereas the contingen-
cy coefficient phi was used on assessing correlations 
between nominal variables. A value of  P<0.05 was 
considered significant. Statistical analyses were per-
formed by using the SPSS v 17.01 statistical package 
(Chicago, il).
Results
during the 6-year study period, 50 lobular breast 
carcinomas were diagnosed, accounting for 8.08% 
of all breast carcinomas. All patients were women 
aged 33-83, ten (20%) of them premenopausal and 
40 (80%) postmenopausal. There was no difference in 
the prevalence of ilC between the left and the right 
breast. Histologic features of classic type ilC were 
recorded in 66% and one of the variant types of ilC 
(5 pleomorphic, 2 solid, 2 alveolar and 8 mixed types) 
in 34% of cases. The size of invasive tumor focuses 
ranged from 0.2 to 7 cm and the number of tumor fo-
cuses varied from one to six. in most cases, i.e. in 74% 
of ilC analyzed, there was one tumor focus, showing 
mostly classic histologic type. Also, the variant types 
of ilC most commonly presented as one tumor fo-
cus. more than three tumor foci were found in 10% 
of ilC, with a similar ratio in the classic and variant 
types. 
Concomitant lobular intraepithelial neoplasia 
(lin) was found in 35 (70%) ilC, with the majority 
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of them being defined as a classic type of ilC. ductal 
component including in situ and invasive forms was 
present in 7 (14%) ilC, mostly of classic type. Other 
proliferative and preneoplastic breast lesions, such as 
different degrees of ductal hyperplasia with and with-
out atypia, intraductal papilloma and papillomatoses 
were found in 10 (20%) cases. There was a significant 
negative correlation between histologic subtypes and 
presence of other proliferative lesions in the classic 
type in comparison with variant types of ilC (27.3% 
vs. 5.9%; p=0.046). in 18% of patients, a multicentric, 
bilateral or mixed type of breast cancer (lobular and 
ductal simultaneously) was diagnosed. 
ilC, unclassified in subtypes, was found in women 
aged 58 as one tumor focus, without axillary metasta-
ses, with maximum (3+) of both er and Pr expression 
and negative Her2/neu. However, mann-whitney 
u test yielded differences in some quantitative vari-
ables between the classic and variant subtypes of ilC. 
The median tumor size, t and n status, number of 
positive lymph nodes and estrogen receptors were sig-
nificantly higher in variant types of ilC (table 1). 
er was positive in 41 (82%) cases of ilC (fig. 1). 
in 54% of carcinomas, both histologic groups showed 
maximal expression (3+), (table 2). Pr was also posi-
tive in the majority of tumors (n=39, 78%) (fig. 2), 
with maximum level of expression (3+) in 44% of car-
cinomas of both histologic groups (table 3). in most 
cases (68%), er and Pr showed simultaneous expres-
sion. 
Only one tumor was Her2/neu 3+; it was ilC of 
the classic type, er and Pr negative.
in the total sample, not divided by different histo-
logic subtypes, we found a positive correlation between 
er and Pr (p=0.004) as well as between tumor size 
and n status (p=0.005). There was a negative correla-










25 50(median) 75 25
50
(median) 75
Age 33  55.5 61.0 69.5 17 48.5 55.0 63.0 0.069
tumor
size (cm) 33 0.9 1.5 2.7 17 1.8 2.5 4.0 0.001
focus (n) 33 1.0 1.0 2.0 17 1.0 1.0 1.5 0.821
Status t 33 1.0 1.0 2.0 17 1.0 2.0 2.0 0.012
Status n 33 0.0 0.0 1.0 17 0.0 1.0 2.0 0.028
Positive lymph 
node (n) 33 0.0 0.0 4.0 17 0.0 2.0 7.0 0.044
er 33 1.0 2.0 3.0 17 2.5 3.0 3.0 0.047
Pr 33 0.5 2.0 3.0 17 1.0 3.0 3.0 0.473
Her2/neu 33 0.0 0.0 1.0 17 0.0 0.0 0.0 0.031
Fig. 1. positive estrogen receptors (+++) in invasive lobular 
carcinoma determined by immunohistochemistry (MSIp, 
X200).
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tion between Her2/neu and n status (p=0.042) in 
the total sample. The aforementioned correlations also 
applied to the classic histologic type. in variant types, 
we found a significant positive correlation between t 
status and n status (p=0.021) and negative correla-
tion between er expression and t status (p=0.044). 
A significant positive correlation (p=0.003) was ob-
served between the patient menopausal status and er 
expression. Another interesting result emerged from 
this study, namely, that in premenopausal women 
younger than 50, the ratio between er positive and 
er negative ilC was the same (with five patients 
in each group). lin had a higher prevalence in er 
positive ilC (in 27 of 41 er positive tumors); con-
comitant ductal component was also more frequently 
found in er positive tumors and in only one er neg-
ative tumor. Our results showed a significant nega-
tive correlation between er expression and presence 
of other proliferative and precancerous breast lesions 
(p=0.043); er expression in ilC correlated signifi-
cantly with a lower prevalence of other proliferative 
breast lesions. 
Pr was also more frequently expressed in post-
menopausal patients (in 31 of 40 patients in post 
menopause), however, without any statistical signifi-
cance, which, in contrast, was found in er expression. 
it is interesting that Pr was more often expressed in 
premenopausal women (in 8 of 10 patients), while er 
was positive and negative in the same ratio in this 
group of patients. lin also had a higher prevalence in 
Pr positive ilC (in 29 of 39 Pr positive ilC) as well 
as concomitant ductal component, which was found in 
only one Pr negative ilC. Other proliferative breast 
lesions also were more frequently detected in Pr posi-
tive (9 of 10 ilC with the presence of other prolif-
erative lesions) than in Pr negative ilC, whereas its 
presence in er positive tumors showed a statistically 
significant negative correlation.
Fig. 2. positive progesterone receptors (+++) in invasive lobu-
lar carcinoma determined by immunohistochemistry (MSIp, 
X200).
Table 2. Intensity of estrogen receptor (ER) expression in 
histologic subtypes of invasive lobular breast carcinoma
Histologic subtype totalClassic variant
er
0 n 7 2 9% 21.2 11.8 18.0
1 n 4 1 5% 12.1 5.9 10.0
2 n 8 1 9% 24.2 5.9 18.0
3 n 14 13 27% 42.4 76.5 54.0
total n 33 17 50% 100.0 100.0 100.0
χ²-test, p=0.138
Table 3. Intensity of progesterone receptor (pR) expression in 
histologic subtypes of invasive lobular breast carcinoma
  Histologic  subtype total   Classic variant
Pr
0 n 8 3 11% 24.2 17.6 22.0
1 n 2 2 4% 6.1 11.8 8.0
2 n 10 3 13% 30.3 17.6 26.0
3 n 13 9 22 % 39.4 52.9 44.0
total n 33 17 50%  100.0 100.0 100.0
χ²-test, p=0.607
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Discussion 
A review of recent literature revealed just few 
studies that focused on different features of histologic 
subtypes of lobular carcinoma through possible epide-
miological and clinical differences among them, as in 
the expression of hormone receptors and Her2/neu 
oncoprotein. 
The prevalence of ilC recorded in our study for 
the 2003-2008 period (8.08%) is in line with com-
parable data already reported in the literature, e.g., 
5%-15% according to wHO3. eighty percent of 
women with ilC were postmenopausal, which is in 
agreement with data from the literature3,7,8. in the last 
twenty years, an increasing trend in the prevalence of 
ilC in women over 50 years of age has been noticed, 
which can partly be explained by a growing number of 
women receiving hormonal therapy. Thus, the theory 
of a greater hormone dependence of lobular in com-
parison with ductal carcinoma, as advocated by some 
authors, can be corroborated3,6,7.  
diCostanzo et al. revealed an 8%-19% incidence 
of contralateral ilC, which is higher than the inci-
dence of contralateral idC9. Arpino et al. emphasize 
that the incidence of bilateral ilC is twice as high as 
the incidence of bilateral idC6. Thus, they point to 
the importance of taking tamoxifen in women with 
ilC to prevent contralateral carcinoma. in the pres-
ent study, 18% of our patients developed bilateral or 
mixed carcinoma during the study period. dixon et al. 
found the classic type of ilC to include lCiS in more 
than 90% of cases10. However, our study provided evi-
dence for not only of lCiS, but also for lin. 
er positive tumors are more likely to occur in old-
er women, they are often of a lower histologic grade, 
usually diploid, with lower mitotic activity, and they 
rarely show expression of p53 and Her2/neu11. Our 
results showed that er was more frequently expressed 
in ilC, i.e. in 41 (82%) carcinomas. Sastre-garau et 
al. found that 70%-95% of ilC cases were er posi-
tive, which is higher than 70%-80% er positive idC 
cases12. in the study by bane et al., based on 50 ilCs, 
all ilCs observed were er positive irrespective of 
the patient age or size and grade of tumors, as usually 
found in the literature7. Previous data suggest the role 
of er as a nondiscriminative prognostic factor in the 
treatment of ilC. Our study showed that in the clas-
sic and variant types of ilC, maximal or 3+ level of 
er was most frequently observed. nesland et al. also 
confirmed the existence of er in the classic and vari-
ant types of ilC, with almost 100% of er positivity 
in the alveolar type, whereas the ratio of er positiv-
ity in the pleomorphic variant was lower than in the 
classic type13.
Pr expression also has a prognostic as well as pre-
dictive value in the treatment of breast carcinomas. 
Pr expression seems to be the reflection of functional 
er in tumors, and in this way Pr predicts patient 
response to adjuvant endocrine therapy11,14. However, 
its role as an independent prognostic marker does not 
seem to be so important. According to our results, 
Pr was expressed in 39 (78%) cases of ilC. Sastre-
garau et al. found Pr expression in 60%-70% of ilC 
cases, which is slightly lower in comparison with our 
results12. bane et al. demonstrated a high incidence of 
Pr positive ilCs (85%-90%), without any correlation 
between Pr status and tumor size7. Our study indi-
cated that the classic and variant types of ilC most 
often showed maximal or 3+ Pr expression. Classic 
ilC, which correlates with grade i ilC, is known to 
have a high incidence (>90%) of Pr expression7,15. 
The higher expression of Her2/neu is associated 
with higher grade and bigger tumors, with negative 
er and Pr, and with positive axillary lymph nodes; 
therefore, it correlates with poor disease prognosis16,17. 
it is significantly more often expressed in idC than 
ilC, where it is most often negative3. in 50 ilC cases 
presented in our study, only one was Her2/neu posi-
tive (3+); it was an ilC of the classic type, with si-
multaneous er and Pr negative expression. Porter et 
al. report that Her2/neu is significantly more often 
expressed in pleomorphic types in comparison with 
other ilC types18. Hoff et al. found Her2/neu am-
plification in 0% of special types of breast carcinomas 
and in less than 1% of ilCs, almost always in those of 
pleomorphic type with high nuclear grade19. 
Conclusion
Our results revealed statistically significant dif-
ferences in tumor status between histologic subtypes 
of ilC, whereas er and Pr expression was equally 
distributed among the classic and variant types. This 
study as well as relevant data from recent literature 
proves that ilC is a distinct biological and clinical 
entity that needs to be further investigated, so that 
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thorough understanding of its biology might enable 
selective approach in choosing the most appropriate 
surgical and oncologic treatment. The results present-
ed in this paper will surely contribute to the modest 
insights into the biological and morphological organi-
zation of lobular breast carcinoma and its morpholog-
ical subtypes available so far. They will aim at possible 
differential therapeutic directions in women with this 
type of breast cancer. 
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Sažetak 
HiStOlOŠKi POdtiPOvi invAZivnOg lObulArnOg KArCinOmA u KOrelACiJi
S tumOrSKim StAtuSOm i HOrmOnSKim reCePtOrimA
I. Miše, M. Vučić, I. Maričević, M. Šokčević i S. Čurić-Jurić
invazivni lobularni karcinom je zaseban biološki i klinički entitet s nekoliko različitih histoloških podtipova progno-
stička vrijednost kojih je još uvijek nedovoljno jasna. Cilj rada bio je odrediti imunohistokemijsku izražajnost er i Pr 
u podtipovima lobularnog karcinoma dojke (klasični i varijantni) i korelirati ih s kliničkim i tumorskim parametrima. 
Analizirano je 50 invazivnih lobularnih karcinoma, 33 klasičnog i 17 varijantnog tipa. Klasični tip bio je češći (66%), 
prosječno u nešto starijih žena (61 god.), manje veličine (1,5 cm), statusa n0 i s umjereno pozitivnim er i Pr. varijantni 
tipovi bili su češći kod nešto mlađih žena (55 god.), prosječno veći (2,5 cm), statusa n1 i s maksimalno pozitivnim er i 
Pr. er je bio izraženi u 82%, Pr u 78% svih tumora, oba receptora najčešće s maksimalnom ekspresijom. Svega jedan 
tumor bio je Her2/neu 3+, istodobno er i Pr-, po tipu klasičan. izražajnost er bila je značajno povezana s manjom 
učestalošću drugih proliferirajućih lezija (p=0,043). Za cijeli uzorak i klasični tip bila je značajna pozitivna korelacija er 
i Pr (p=0,004), također između veličine tumora i statusa n (p=0,005) te negativna korelacija Her/2neu i statusa n 
(p=0,042). u varijantnim tipovima veći tumori značili su veći n (p=0,021), a veća izražajnost er bila je povezana s ma-
njim tumorima (p=0,044). rad je pokazao jasna biološka obilježja podtipova lobularnog karcinoma i potrebu selektivnijeg 
terapijskog pristupa. 
Ključne riječi: Novotvorine dojke – dijagnostika; Novotvorine dojke – patologija; Karcinom, lobularni – dijagnostika; Karci-
nom, lobularni – patologija; Određivanje stadija novotvorine; Starenje; Žene

